Nicotine Wrafton Laboratories Limited (Nicotine Resinate)

Nicotine Resinate is a nicotinic agonist used in smoking cessation therapy.

• Smoking cessation: helps adults reduce cravings and withdrawal symptoms when quitting tobacco.
• Nicotine dependence: supports gradual reduction of nicotine intake.
• Relapse prevention: assists in maintaining abstinence after quitting.

• Nicotine Resinate binds to and activates nicotinic acetylcholine receptors in the central nervous system, mimicking the action of nicotine. This activation reduces the intensity of withdrawal symptoms and cravings by providing a controlled level of receptor stimulation, thereby facilitating the transition away from tobacco use without the harmful constituents of smoke.

Nicotine Resinate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Mouth irritation: tingling or soreness in the oral cavity.
• Headache: occasional mild headache.
• Dizziness: brief episodes of light‑headedness.
• Insomnia: difficulty falling or staying asleep.
• Unusual taste: metallic or bitter sensation.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Chest pain: unexpected discomfort in the chest area.
• Severe hypertension: sudden rise in blood pressure.
• Cardiac arrhythmia: irregular heart rhythm.
• Seizures: rare convulsive episodes.
• Respiratory distress: shortness of breath or wheezing.

Before using Nicotine Resinate, consider the following safety measures.

• Cardiovascular assessment: evaluate blood pressure and heart disease status.
• Contraindication with uncontrolled heart conditions: avoid if severe cardiac disease is present.
• Avoid concurrent nicotine products: do not combine with patches, gum, or inhalers.
• Monitor for signs of nicotine toxicity: watch for vomiting, rapid heart rate, or confusion.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Nicotine Resinate can interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors: may precipitate hypertensive crisis.
• Other nicotine products: risk of nicotine overdose.
• CYP2A6 inhibitors: can increase nicotine plasma levels.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors: may enhance side‑effects such as nausea.
• Beta‑blockers: nicotine‑induced tachycardia may be masked.
• Alcohol: combined use can intensify central nervous system effects.